Oncolytics Biotech Inc. (ONCY) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Market Cap | 114.96M |
| Enterprise Value | 108.59M |
| P/E Ratio | -2.03 |
| PEG Ratio | 0.08 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | -13.53 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | -1.77 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | June 30, 2026 |
| Profit Margin | 0 |
| Operating Margin | 0 |
| Return On Assets | -4.98 |
| Return On Equity | 10.2 |
| Revenue | 0 |
| Revenue/Share | 0 |
| Gross Profit | 0 |
| EBITDA | -28.66M |
| Net Income | -28.76M |
| Diluted EPS | -0.41 |
| Total Cash | 4.12M |
| Total Cash/Share | 0.03 |
| Total Debt | 448,000 |
| Total Debt/Equity | -0.07 |
| Current Ratio | 1.35 |
| Book Value Per Share | -0.05 |
| 52-Week Change | -55.39 |
| 52-Week High | 1.32 |
| 52-Week Low | 0.44 |
| Moving Average 50 Days | 0.72 |
| Moving Average 200 Days | 0.88 |
| Average Volume | 1.06M |
| Shares Outstanding | 100.36M |
| % Held by Institutions | 3.54 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 2:19 |
| Last Split Date | May 25, 2018 |